For instance, MI-2 significantly decreased anti-apoptotic proteins such as BCL2 and MCL-1 (myeloid leukemia 1) and activated the intrinsic apoptosis pathway in chronic lymphocytic leukemia [41]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.